PepGen (PEPG) Cash & Equivalents (2021 - 2026)

PepGen has reported Cash & Equivalents for 6 years, with the latest figure at $42.2 million in Q1 2026.

• Quarterly Cash & Equivalents fell 3.4% year-over-year to $42.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.2 million (down 3.4% YoY) and the FY2025 annual result came in at $60.5 million, up 22.45% from the prior year.
• Cash & Equivalents retreated to $42.2 million in Q1 2026 per PEPG's latest filing, from $60.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $218.8 million in Q2 2022 and troughed at $35.1 million in Q2 2025.
• A 5-year average of $109.0 million and a median of $118.9 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents surged 1682.72% in 2022, then tumbled 67.4% in 2025.
• Over 5 years, Cash & Equivalents stood at $181.8 million in 2022, then plunged by 55.56% to $80.8 million in 2023, then slumped by 38.82% to $49.4 million in 2024, then climbed by 22.45% to $60.5 million in 2025, then tumbled by 30.35% to $42.2 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $42.2 million, $60.5 million, and $142.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.